The 'check effect' reconsidered

Addiction

Volumn 106, Issue 6, 2011, Pages 1071-1077

  Rosen, Marc I ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Case management; Disability benefits; Dual diagnosis (psychiatric); Financial support; Mental disorders; Representative payee; Substance related disorders

Indexed keywords

STREET DRUG;

ADDICTION; ALCOHOLIC BEVERAGE; CASE MANAGEMENT; CUSTODY; DRINKING BEHAVIOR; ECONOMICS; HOMELESSNESS; HUMAN; INSURANCE; MENTAL DISEASE; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL SECURITY; TIME; UNITED STATES; VETERAN;

ALCOHOL DRINKING; ALCOHOLIC BEVERAGES; CASE MANAGEMENT; DIAGNOSIS, DUAL (PSYCHIATRY); HOMELESS PERSONS; HUMANS; INSURANCE, DISABILITY; MENTAL DISORDERS; PROXY; SOCIAL SECURITY; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; UNITED STATES; VETERANS;

EID: 79955887864     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03409.x     Document Type: Review

References (63)

1. Shaner A., Eckman T. A., Roberts L. J., Wilkins J. N., Tucker D. E., Tsuang J. W. etal. Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers-a government-sponsored revolving door. N Engl J Med 1995; 333: 777-83.
2. Satel S. L. When disability benefits make patients sicker. N Engl J Med 1995; 333: 794-6.
3. Phillips D. P., Christenfeld N., Ryan N. M. An increase in the number of deaths in the United States in the first week of the month-an association with substance abuse and other causes of death. N Engl J Med 1999; 341: 93-8.
4. Epstein D. H., Willner-Reid J., Vahabzadeh M., Mezghanni M., Lin J.-L., Preston K. L. Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Arch Gen Psychiatry 2009; 66: 88-94.
5. O'Brien C. P., Childress A. R., McLellan A. T., Ehrman R. Classical conditioning in drug-dependent humans. Ann NY Acad Sci 1992; 654: 400-15.
6. Grossman L. S., Willer J. K., Miller N. S., Stovall J. G., McRae S. G., Maxwell S. Temporal patterns of veterans psychiatric service utilization, disability payments, and cocaine use. J Psychoact Drugs 1997; 29: 285-90.
7. Catalano R., McConnell W. Psychiatric emergencies: the check effect revisited. J Health Soc Behav 1999; 40: 79-86.
8. Halpern S. D., Mechem C. C. Declining rate of substance abuse throughout the month. Am J Med 2001; 110: 347-51.
9. Catalano R., McConnell W., Forster P., McFarland B., Shumway M., Thornton D. Does the disbursement of income increase psychiatric emergencies involving drugs and alcohol? Health Serv Res 2000; 35: 813-23.
10. Maynard C., Cox G. B. Datapoints: association between week of the month and hospitalization for substance abuse. Psychiatr Serv 2000; 51: 31.
11. Svikis D., Pickens R., Schweitzer W., Johnson E., Haug N. Weekly patterns of drug treatment attendance. Am J Public Health 1999; 89: 752-5.
12. Li X., Sun H., Marsh D. C., Anis A. H. Impact of welfare cheque issue days on a service for those intoxicated in public. Harm Reduct J 2007; 4. Available from (accessed 12 April 2011; archived by Webcite at ).
13. Herbst M. D., Batki S. L., Manfredi L. B., Jones T. Treatment outcomes for methadone clients receiving lump-sum payments at initiation of disability benefits. Psychiatr Serv 1996; 47: 119-20.
14. Satel S., Reuter P., Hartley D., Rosenheck R., Mintz J. Influence of retroactive disability payments on recipients compliance with substance abuse treatment. Psychiatr Serv 1997; 48: 796-9.
15. Stephens M. Paycheck Receipt and the Timing of Consumption. Working Paper 9356 (serial on the internet). 2002. Available at: (accessed 5 May 2010).
16. Shapiro J. M. Is there a daily discount rate? Evidence from the food stamp nutrition cycle. J Public Econ 2005; 89: 303-25.
17. Bickel W. K., Marsch L. A. Toward a behavioral economic understanding of drug dependence: delay discounting processes. Addiction 2001; 96: 73-86.
18. Reynolds B., Richards J. B., de Wit H. Acute-alcohol effects on the Experiential Discounting Task (EDT) and a question-based measure of delay discounting. Pharmacol Biochem Behav 2006; 83: 194-202.
19. Petry N. M. Discounting of money, health, and freedom in substance abusers and controls. Drug Alcohol Depend 2003; 71: 133-41.
20. Dobkin C., Puller S. L. The effects of government transfers on monthly cycles in drug abuse, hospitalization and mortality. J Public Econ 2007; 91: 2137-57.
21. Rosenheck R. A., Frisman L. K. An increase in the number of deaths in the United States in the first week of the month-an association with substance abuse and other causes of death. (letter). N Engl J Med 1999; 341: 1548.
22. Maynard C. Association between week of the month and death from acute myocardial infarction in Washington State, 1988 to 1997. Am Heart J 2000; 140: 196-9.
23. Frisman L. K., Rosenheck R. A. The relationship of public support payments to substance abuse among homeless veterans with mental illness. Psychiatr Serv 1997; 48: 792-5.
24. Rosenheck R. A., Frisman L. K. Do public support payments encourage substance abuse. Health Aff 1996; 15: 192-200.
25. Rosen M. I., McMahon T. J., Lin H., Rosenheck R. A. Effect of social security payments on substance abuse in a homeless mentally ill cohort. Health Serv Res 2006; 41: 173-91.
26. Swartz J. A., Hsieh C. M., Baumohl J. Disability payments, drug use and representative payees: an analysis of the relationships. Addiction 2003; 98: 965-75.
27. Rosenheck R. A., Dausey D. J., Frisman L., Kasprow W. Outcomes after initial receipt of social security benefits among homeless veterans with mental illness. Psychiatr Serv 2000; 51: 1549-54.
28. Tsemberis S., Gulcur L., Nakae M. Housing First, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. Am J Public Health 2004; 94: 651-6.
29. Cheng A.-L., Lin H., Kasprow W., Rosenheck R. A. Impact of supported housing on clinical outcomes: analysis of a randomized trial using multiple imputation technique. J Nerv Ment Dis 2007; 195: 83-8.
30. Festinger D. S., Marlowe D. B., Dugosh K. L., Croft J. R., Arabia P. L., Festinger D. S. etal. Higher magnitude cash payments improve research follow-up rates without increasing drug use or perceived coercion. Drug Alcohol Depend 2008; 96: 128-35.
31. Guydish J., Ponath C., Bostrom A Campbell K. M., Barron N. Effects of losing SSI benefits on standard drug and alcohol outcome measures. Contemp Drug Probl 2003; 30: 169-94.
32. Speiglman R., Norris J., Kappagoda S., Green R. S., Martinovich Z. SSI receipt and alcohol and other drug use among former SSI DA&A beneficiaries. Contemp Drug Probl 2003; 30: 291-333.
33. Swartz J. A., Baumohl J., Lurigio A. J. Termination of supplemental security income benefits for drug addiction and alcoholism: results of a longitudinal study of the effects on former beneficiaries. Soc Serv Rev 2004; 78: 96-124.
34. Watkins K. E., Podus D. The impact of terminating disability benefits for substance abusers on substance use and treatment participation. Psychiatr Serv 2000; 51: 1371-81.
35. Goldfinger S. M., Schutt R. K., Tolomiczenko G. S., Seidman L., Penk W. E., Turner W. etal. Housing placement and subsequent days homeless among formerly homeless adults with mental illness. Psychiatr Serv 1999; 50: 674-9.
36. Lipton F. R., Siegel C., Hannigan A., Samuels J., Baker S. Tenure in supportive housing for homeless persons with severe mental illness. Psychiatr Serv 2000; 51: 479-86.
37. Appelbaum P. S., Redlich A. Use of leverage over patients' money to promote adherence to psychiatric treatment. J Nerv Ment Dis 2006; 194: 294-302.
38. Elbogen E. B., Swanson J. W., Swartz M. S., Wagner H. R. Characteristics of third-party money management for persons with psychiatric disabilities. Psychiatr Serv 2003; 54: 1136-41.
39. Conrad K. J., Matters M. D., Luchins D., Hanrahan P., Quasius D. L., Lutz G. Development and cross-validation of a money mismanagement measure. J Appl Meas 2006; 7: 206-24.
40. Thaler R. H. Mental accounting matters. J Behav Decis Mak 1999; 12: 183-206.
41. Kahneman D., Tversky A. Choices, values and frames. Am Psychol 1984; 39: 341-50.
42. Rosen M. I., Carroll K. M., Stefanovics E., Rosenheck R. A., Rosen M. I., Carroll K. M. etal. A randomized controlled trial of a money management-based substance use intervention. Psychiatr Serv 2009; 60: 498-504.
43. Rosen M. I., Rounsaville B. J., Ablondi K., Black A. C., Rosenheck R. A. Advisor-teller money manager (ATM) therapy for substance abuse. Psychiatr Serv 2010; 61: 707-13.
44. Black A. C., Rosen M. I. A money management-based substance use treatment increases valuation of future rewards. Addict Behav 2011; 36: 125-8.
45. Kirby K. N., Petry N. M., Bickel W. K. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 1999; 128: 78-87.
46. Rosen M. I., Rosenheck R. A. Substance use and assignment of representative payees. Psychiatr Serv 1999; 50: 95-8.
47. Conrad K. J., Matters M. D., Hanrahan P., Luchins D. J., Savage C., Daugherty B. Characteristics of persons with mental illness in a representative payee program. Psychiatr Serv 1998; 49: 1223-5.
48. Luchins D. J., Hanrahan P., Conrad K. J., Savage C., Matters M. D., Shinderman M. An agency-based representative payee program and improved community tenure of persons with mental illness. Psychiatr Serv 1998; 49: 1218-22.
49. Rosen M. I., McMahon T. J., Rosenheck R. A. Does assigning a representative payee reduce substance abuse? Drug Alcohol Depend 2007; 86: 115-22.
50. Moser L. L., Bond G. R. Scope of agency control: assertive community treatment teams' supervision of consumers. Psychiatr Serv 2009; 60: 922-8.
51. Ries R. K., Dyck D. G. Representative payee practices of community mental health centers in Washington State. Psychiatr Serv 1997; 48: 811-4.
52. US Social Security Administration. Final Report. Representative Payment Advisory Committee. Baltimore, MD: US Social Security Administration; 1996.
53. Black R. A., Rounsaville B. J., Rosenheck R. A., Conrad K. J., Ball S. A., Rosen M. I. etal. Measuring money mismanagement among dually diagnosed clients. J Nerv Ment Dis 2008; 196: 576-9.
54. Rosen M. I., Rosenheck R. A., Shaner A. L., Eckman T. A., Gamache G. R., Krebs C. W. Veterans who may need a payee to prevent misuse of funds for drugs. Psychiatr Serv 2002; 53: 995-1000.
55. Rosen M. I., Rosenheck R. A., Shaner A. L., Eckman T. A., Gamache G. R., Krebs C. W. Substance abuse and the need for money management assistance among psychiatric inpatients. Drug Alcohol Depend 2002; 67: 331-4.
56. Rosen M. I., Bailey M., Dombrowski E., Ablondi K., Rosenheck R. A. A comparison of satisfaction with clinician, family members/friends and attorneys as payees. Commun Ment Health J 2005; 41: 291-306.
57. Elbogen E. B., Soriano C., Van Dorn R., Swartz M. S., Swanson J. W. Consumer views of representative payee use of disability funds to leverage treatment adherence. Psychiatr Serv 2005; 56: 45-9.
58. Dixon L., Turner J., Krauss N., Scott J., McNary S. Case managers' and clients' perspectives on a representative payee program. Psychiatr Serv 1999; 50: 781-6.
59. Elbogen E. B., Swanson J. W., Swartz M. S., Van Dorn R. Family representative payeeship and violence risk in severe mental illness. Law Hum Behav 2005; 29: 563-74.
60. Ries R. K., Comtois K. A. Managing disability benefits as part of treatment for persons with severe mental illness and comorbid drug/alcohol disorders. A comparative study of payee and non-payee participants. Am J Addict 1997; 6: 330-8.
61. Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res 1999; 35: S93-100.
62. Rosen M. I., Desai R., Bailey M., Davidson L., Rosenheck R. Consumer experience with payeeship provided by a community mental health center. Psychiatr Rehabil J 2001; 25: 190-5.
63. Conrad K. J., Lutz G., Matters M. D., Donner L., Clark E., Lynch P. Randomized trial of psychiatric care with representative payeeship for persons with serious mental illness. Psychiatr Serv 2006; 57: 197-204.